SCHEMBL17592991

SCHEMBL17592991

C[Si](C)(C)CCOCN(c1ncccn1)S(=O)(=O)c1ccc2c(c1)CCN2C(=O)c1cc(-c2ccccc2)[nH]n1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.38
▸ GAA P10253 2/20 0.38
▸ TSHR P16473 2/20 0.37
▸ TRIM24 O15164 2/20 0.37
▸ ALDH1A1 P00352 4/20 0.36
▸ HTT P42858 3/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ HPGD P15428 3/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ADRB2 P07550 1/20 0.35
▸ ADRB1 P08588 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17593059 0.89 ALDH1A1 (0.39) LMNAGAATSHRALDH1A1HTT
SCHEMBL17593165 0.78 TRIM24 (0.49) TRIM24SMN1; SMN2POLBMEN1KMT2A
SCHEMBL17592909 0.73 CA12 (0.36) ALDH1A1SMN1; SMN2
SCHEMBL17593239 0.69 PHGDH (0.54) LMNAGAASMN1; SMN2USP2HPGD
SCHEMBL17593148 0.68 ADRB2 (0.44) TSHRTRIM24SMN1; SMN2POLBMEN1
SCHEMBL17593076 0.66 NPC1 (0.44) LMNAGAAHTTSMN1; SMN2KDM4E
SCHEMBL17592956 0.65 CYP2C8 (0.42) LMNATSHRALDH1A1SMN1; SMN2HPGD
SCHEMBL19332471 0.64 CA1 (0.38) LMNAALDH1A1HTTKDM4E
SCHEMBL17593251 0.63 L3MBTL1 (0.40) LMNAALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL17593235 0.63 TP53 (0.52) LMNASMN1; SMN2KDM4EPOLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016040449-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2016-03-17 — — WO disclosed
Send feedback